CLINICAL TRIALS
Dendreon has ongoing Phase 2 PHASE 2 CLINICAL TRIALA study to assess the preliminary efficacy of a treatment at the dose and dosing schedule determined in the Phase 1 trial and to provide further safety information (for example, whether it shrinks a tumor or improves blood test results).Close and Phase 3 PHASE 3 CLINICAL TRIALA study to compare the results of people taking a new treatment with the results of people taking the standard treatment (for example, which group has better survival rates or fewer side effects). In most cases, studies move into Phase 3 only after a treatment seems to work in Phase 2. Phase 3 trials may include hundreds of people.Close studies.
Sipuleucel-T Clinical Studies
P10-1
- An Open-Label, Multicenter Study of Sipuleucel-T in Metastatic Castrate Resistant Prostate Cancer Patients Previously Treated with Sipuleucel-T on Dendreon Study P-11
- To learn more about the eligibility criteria and to find a clinical research facility nearest you, please click here or go to http://www.clinicaltrials.gov.
P10-2
- A Randomized, Open-Label, Phase 2 Trial Examining the Sequencing of Sipuleucel-T and Androgen Deprivation Therapy in Men with Non-Metastatic Prostate Cancer and a Rising Prostate Specific Antigen After Primary Therapy.
- To learn more about the eligibility criteria and to find a clinical research facility nearest you, please click here or go to http://www.clinicaltrials.gov.
P10-3 (called PROCEED)
- A Registry of Sipuleucel-T in Men with Advanced Prostate Cancer (called PROCEED) to Further Evaluate Safety and Survival Associated with Sipuleucel-T
- To learn more about the eligibility criteria and to find a clinical research facility nearest you, please click here or go to http://www.clinicaltrials.gov.
Additional ACI Product Candidate Clinical Studies
N10-1 (called Neu-ACT)
- A Randomized, Phase 2, Open-Label Study Evaluating DN24-02 as Adjuvant Therapy in Subjects with High Risk HER2+ Urothelial Carcinoma
- To learn more about the eligibility criteria and to find a clinical research facility nearest you, please click here or go to http://www.clinicaltrials.gov.